influenza
virus
envelop
virus
belong
orthomyxovirida
famili
caus
agent
influenza
four
recogn
influenza
type
denot
b
c
recent
discov
influenza
virus
iav
abl
infect
wide
rang
avian
mammalian
speci
includ
human
mostli
exist
wild
aquat
fowl
reservoir
iav
associ
pandem
human
mainli
abil
infect
differ
host
reassort
genom
freeli
replic
absenc
preexist
immun
human
contrast
influenza
b
virus
ibv
mainli
restrict
adapt
human
although
sporad
infect
seal
document
restrict
infect
human
ibv
respons
date
human
pandem
influenza
c
virus
icv
normal
caus
mild
respiratori
ill
human
thought
caus
epidem
pandem
newli
identifi
influenza
virus
idv
primarili
affect
cattl
pig
date
known
infect
caus
ill
human
iav
ibv
infect
repres
seriou
public
health
problem
caus
contagi
respiratori
diseas
substanti
morbid
mortal
human
result
consider
econom
burden
worldwid
public
health
concern
pose
iav
ibv
human
aggrav
abil
effici
transmit
limit
antivir
therapeut
option
treatment
viral
infect
iav
divid
multipl
subtyp
base
two
glycoprotein
locat
surfac
viru
hemagglutinin
ha
neuraminidas
na
figur
new
gener
implement
sequenc
technolog
well
develop
better
bioinformat
tool
help
discov
novel
subtyp
iav
current
ha
na
iav
subtyp
howev
iav
subtyp
present
circul
human
iav
respons
annual
global
epidem
effect
prevent
annual
vaccin
reduc
transmiss
futur
infect
impact
iav
intensifi
occurr
pandem
novel
virus
introduc
human
popul
instanc
first
influenza
pandem
centuri
declar
emerg
quadruplereassort
swineorigin
iav
estim
one
year
pandem
iav
infect
individu
around
world
caus
near
human
death
countri
hand
ibv
divid
two
major
lineag
cocircul
human
popul
victoria
yamagatalik
lineag
two
lineag
diverg
ancestr
influenza
although
perceiv
less
danger
iav
ibv
infect
caus
annual
outbreak
respiratori
ill
associ
excess
morbid
mortal
pediatr
popul
typic
ibv
epidem
less
sever
iav
sever
iav
adult
elderli
popul
two
major
evolutionari
mechan
respons
season
pandem
influenza
first
antigen
drift
characterist
share
rna
virus
involv
introduct
mutat
viral
genom
lead
select
viral
mutant
resist
current
antivir
andor
neutral
antibodi
nab
second
segment
natur
iav
genom
allow
exchang
viral
segment
differ
viral
strain
coinfect
cell
antigen
shift
reassort
event
lead
new
pandem
viru
new
viru
introduc
human
popul
given
abil
iav
modifi
genom
rapid
transmiss
season
influenza
vaccin
need
reformul
annual
ensur
two
viral
glycoprotein
ha
na
vaccin
match
circul
season
virus
therefor
even
though
vaccin
best
intervent
option
protect
season
iav
infect
effici
current
vaccin
approach
shown
suboptim
influenza
new
prophylact
approach
protect
import
human
viru
highli
desir
despit
countermeasur
influenza
prevent
vaccin
treat
antivir
viral
infect
respiratori
human
pathogen
infect
world
popul
season
epidem
notabl
data
world
health
organ
estim
season
influenza
viru
infect
respons
million
case
sever
diseas
death
worldwid
yearli
http
wwwwhointnewsroomfactsheetsdetailinfluenza
season
current
avail
option
counter
influenza
infect
includ
vaccin
antivir
vaccin
costeffect
approach
due
induct
steril
immun
primari
prophylact
mean
prevent
influenza
viral
infect
first
vaccin
option
chemic
inactiv
influenza
vaccin
iiv
requir
larg
quantiti
viru
induc
nab
suffici
protect
subsequ
infect
howev
iiv
suboptim
limit
cellularmedi
immun
respons
abl
induc
moreov
immunocompromis
elderli
individu
typic
show
reduc
respons
compar
young
healthi
popul
importantli
iiv
limit
protect
season
vaccin
formul
match
predict
circul
strain
recent
influenza
vaccin
made
purifi
recombin
ha
antigen
http
wwwcdcgovfluprotectvaccineqaflublokvaccinehtm
licens
similar
immunogen
characterist
iiv
remain
prophylact
option
live
attenu
influenza
vaccin
laiv
associ
broader
respons
protect
induct
innat
humor
b
tcell
adapt
immun
respons
addit
administr
mimic
usual
rout
influenza
viru
infect
shown
provid
effici
crossreact
cellularmedi
protect
heterolog
influenza
virus
import
case
vaccin
circul
strain
match
howev
current
laiv
remain
restrict
use
healthi
children
nonpregn
adult
independ
type
season
influenza
vaccin
typic
contain
antigen
two
iav
subtyp
one
ibv
subtyp
victoria
andor
yamagatalik
lineag
current
circul
human
worryingli
past
decad
season
influenza
vaccin
shown
low
protect
efficaci
rate
order
improv
effect
current
season
influenza
vaccin
quadrival
influenza
vaccin
formul
includ
ibv
lineag
compon
victoria
yamagatalik
lineag
approv
unit
state
us
food
drug
administr
fda
use
season
howev
efficaci
new
quadrival
laiv
us
shown
even
lower
predecessor
trival
formul
lead
advisori
committe
immun
practic
acip
make
recommend
quadrival
laiv
use
us
howev
current
influenza
season
laiv
includ
among
elig
prophylact
option
prevent
influenza
infect
http
variabl
influenza
vaccin
effici
lead
increas
concern
combat
influenza
viru
infect
protect
popul
season
infect
consequ
new
approach
necessari
prevent
morbid
mortal
associ
influenza
viru
infect
studi
aim
better
understand
biolog
virul
factor
signific
human
respiratori
pathogen
moreov
new
approach
attenu
viru
urgent
need
overcom
limit
associ
current
laiv
public
health
concern
associ
influenza
viral
infect
human
intensifi
limit
therapeut
option
combat
viral
infect
prevent
rapidspread
influenza
virus
therapeut
choic
control
influenza
infect
licens
limit
two
class
fdaapprov
antivir
target
viral
matrix
ion
channel
protein
amantadin
rimantadin
sialidas
activ
site
viral
na
protein
oseltamivir
zanamivir
peramivir
inhibitor
effici
iav
shown
seriou
side
effect
low
efficaci
sinc
current
circul
iav
acquir
resist
hand
na
blocker
effici
iav
ibv
emerg
drugresist
strain
current
increas
although
influenza
virus
shar
similar
structur
characterist
compar
replic
transcript
mechan
review
focu
iav
studi
polymeras
complex
develop
novel
prophylact
strategi
iav
infect
iav
contain
singlestrand
negativesens
viral
v
rna
genom
consist
eight
segment
encapsid
within
envelop
spheric
filament
particl
figur
iav
genom
encod
differ
viral
protein
use
multipl
strategi
overlap
open
read
frame
orf
altern
splice
frameshift
mechan
vrna
segment
flank
termini
noncod
region
ncr
serv
polymeras
promot
viral
genom
replic
gene
transcript
figur
structur
antiparallel
doubl
helic
vrna
coat
viral
nucleoprotein
np
figur
form
viral
ribonucleoprotein
complex
vrnp
vrnp
contain
polymeras
complex
one
end
pseudocircular
vrna
although
influenza
vrna
singlestrand
last
nucleotid
end
partial
complementari
effect
circular
bound
polymeras
complex
iav
polymeras
complex
heterotrimer
structur
approxim
kilodalton
kda
contain
three
protein
subunit
polymeras
basic
respect
acid
pa
protein
togeth
viral
np
allow
vrnp
act
independ
transcriptionrepl
element
infect
cell
figur
viral
ha
na
structur
protein
locat
virion
membran
figur
influenza
viral
transcript
replic
occur
nucleu
infect
cell
use
uniqu
mechan
among
negativesens
rna
virus
upon
releas
vrnp
cytoplasm
infect
cell
vrnp
transport
nucleu
via
process
mediat
viral
np
nucleu
vrna
use
templat
either
transcript
cap
polyadenyl
messeng
rna
replic
complementari
c
rna
figur
new
synthet
polymeras
pa
subunit
np
assembl
form
crnp
progeni
vrnp
produc
replic
crna
intermedi
np
contain
nuclear
local
signal
nl
pa
subunit
associ
viral
import
nucleu
infect
cell
newli
gener
vrnp
transport
nucleu
cytosol
process
mediat
nuclear
export
protein
nep
matrix
protein
plasma
membran
vrnp
encapsid
lipid
envelop
deriv
infect
host
plasma
membran
end
interact
cytoplasm
tail
ha
na
membran
releas
newli
synthes
virion
requir
remov
sa
glycan
cellular
surfac
newli
form
bud
virion
process
mediat
viral
na
freeli
progeni
virus
abl
start
new
replic
cycl
infect
new
target
cell
influenza
compon
contain
rdrp
catalyt
site
core
viral
polymeras
complex
figur
similarli
other
viral
rdrp
structur
iav
characterist
right
hand
fold
contain
finger
palm
thumb
domain
includ
classic
prea
f
ae
polymeras
motif
figur
although
iav
rdrp
bigger
viral
polymeras
compar
figur
iav
rdrp
figur
polioviru
polymeras
conserv
polymeras
region
map
central
region
figur
howev
iav
need
capbind
action
endonucleas
activ
pa
carri
viral
mrna
synthesi
make
whole
transcriptas
complex
significantli
larger
core
rdrp
often
contain
within
singl
protein
rna
virus
iav
possess
n
ctermin
domain
interact
pa
respect
stabil
complex
figur
moreov
contain
nl
figur
although
also
observ
depend
interact
iav
pa
nuclear
import
importantli
uniqu
characterist
viral
rdrp
crucial
role
rna
synthesi
iav
promis
target
gener
identif
novel
antivir
treat
influenza
infect
main
role
iav
polymeras
subunit
product
rna
molecul
cellular
premrna
use
primer
initi
viral
transcript
contain
multipl
function
domain
necessari
perform
viral
rna
synthesi
figur
ntermin
domain
iav
contain
interact
region
figur
figur
ctermin
domain
contain
rna
bind
domain
nl
nuclear
import
cytoplasm
figur
figur
upon
infect
locat
mainli
nucleu
although
also
identifi
mitochondria
ctermin
twothird
iav
contain
capbind
domain
cbd
figur
figur
within
cbd
two
aromat
residu
involv
bind
cap
structur
cap
snatch
process
cellular
mrna
cleav
nucleotid
cap
similarli
cellular
capbind
protein
eukaryot
initi
factor
report
subunit
import
determin
virul
host
rang
restrict
iav
characterist
map
mainli
amino
acid
posit
surround
region
figur
avian
iav
contain
glutam
acid
e
posit
human
iav
lysin
k
although
role
residu
host
adapt
total
understood
describ
bind
cellular
nuclear
protein
could
involv
mechan
host
adapt
moreov
nilsson
et
al
recent
show
essenti
accumul
crna
replic
intermedi
infect
cell
domain
also
essenti
viral
replic
transcript
howev
amino
acid
residu
locat
viral
gene
also
describ
import
viru
host
adapt
iav
also
abl
bind
np
amino
acid
involv
interact
locat
middl
ctermin
region
iav
figur
perform
transcript
vrna
mrna
iav
need
gener
primer
iav
polymeras
cap
activ
reli
cellular
cap
rna
capdonor
process
known
capsnatch
first
cbd
bind
nascent
host
cap
rna
viral
pa
cleav
cap
rna
use
endonucleas
activ
rna
synthesi
complet
rdrp
activ
iav
subunit
figur
figur
iav
pa
subunit
divid
two
main
domain
ntermin
endonucleas
domain
larg
ctermin
domain
tightli
cofold
subunit
figur
endonucleas
catalyt
site
similar
type
ii
endonucleas
contain
two
dival
cation
depend
activesit
coordin
use
catalyt
residu
also
conserv
among
iav
distinct
characterist
iav
endonucleas
multipl
compound
identifi
act
endonucleas
inhibitor
ctermin
region
pa
respons
bind
subunit
figur
shown
iav
pa
form
dimer
cytoplasm
import
nucleu
associ
form
heterotrimer
polymeras
complex
iav
np
multifunct
basic
protein
essenti
replic
viral
genom
transcript
crystal
structur
form
trimer
complex
iav
polymeras
heterotrim
complex
pa
abl
synthes
short
rna
np
requir
process
polymeras
long
rna
templat
np
contain
rnabind
region
nterminu
region
figur
two
domain
respons
npnp
selfinteract
center
ctermin
region
figur
although
phosphoryl
np
could
also
play
role
oligomer
addit
shown
iav
np
also
bind
ntermin
ctermin
region
viral
polymeras
subunit
suggest
potenti
role
regul
viral
polymeras
activ
besid
structur
function
iav
np
compon
viral
crnp
vrnp
np
also
facilit
vrnp
import
nucleu
two
nl
locat
ntermin
central
region
figur
final
iav
np
interact
viral
complex
requir
transloc
vrnp
nucleu
cytosol
infect
cell
latest
step
replic
cycl
iav
current
vaccin
repres
best
prophylact
measur
protect
viral
infect
multipl
strategi
technolog
approach
develop
gener
vaccin
safeti
profil
immunogen
protect
characterist
sever
viral
lav
associ
ts
phenotyp
outstandingli
success
control
infect
multipl
virus
like
ts
mutat
attenu
virus
diminish
viral
replic
pathogenesi
specif
bodi
temperatur
maintain
immunogen
wildtyp
wt
viru
therefor
use
ts
attenu
virus
consid
effect
lav
one
best
prophylact
measur
prevent
diseas
caus
viral
infect
includ
influenza
moreov
case
influenza
laiv
administr
mimic
rout
natur
infect
induc
mucos
immun
import
inhibit
viral
infect
host
upper
respiratori
track
initi
step
viral
infect
consequ
develop
novel
strategi
increas
immunogen
protect
efficaci
current
laiv
approach
similar
higher
safeti
profil
extrem
desir
review
wellknown
ts
mutat
viral
polymeras
iav
discuss
potenti
use
resolv
crystal
structur
iav
polymeras
complex
ration
design
novel
laiv
candid
protect
iav
infect
human
laiv
use
us
gener
adapt
iav
aann
growth
suboptim
decreas
temperatur
multipl
passag
primari
chicken
kidney
tissu
cultur
cktc
cell
figur
ts
adapt
process
aann
gain
multipl
mutat
viral
genom
respons
ts
coldadapt
ca
phenotyp
allow
viru
grow
effici
low
temperatur
howev
viral
replic
restrict
higher
temperatur
found
human
lower
respiratori
tract
febril
process
result
attenu
att
phenotyp
allow
host
mount
effect
immun
respons
infect
upper
airway
nasal
caviti
without
risk
pathogenesi
lower
airway
infect
site
signific
sequela
influenza
infect
current
season
laiv
gener
either
classic
reassort
embryon
chicken
egg
newli
develop
plasmidbas
revers
genet
techniqu
contain
six
intern
gene
pa
np
ns
origin
ts
ca
att
master
donor
viru
mdv
aann
two
viral
glycoprotein
ha
na
predict
circul
season
iav
figur
mutat
respons
ts
ca
att
phenotyp
iav
mdv
aann
use
us
map
three
viral
segment
viral
polymeras
subunit
figur
figur
tabl
red
viral
np
tabl
red
interestingli
union
soviet
socialist
republ
ussr
two
differ
ts
ca
att
iav
mdv
deriv
viru
strain
gener
use
prepar
season
laiv
mdv
obtain
sequenti
passag
addit
passag
wt
chicken
embryon
egg
mdv
obtain
similarli
sequenti
addit
passag
chicken
embryon
egg
interestingli
four
differ
genet
chang
involv
ts
ca
att
phenotyp
mdv
locat
three
viral
segment
nep
figur
figur
tabl
magenta
although
genet
chang
respons
ts
ca
phenotyp
well
character
viru
contain
three
addit
amino
acid
substitut
np
compar
figur
figur
tabl
blue
mdv
attenu
use
vaccin
children
less
year
age
russia
howev
sinc
mdv
show
reduc
immunogen
compar
use
discontinu
contribut
differ
amino
acid
chang
polymeras
compon
current
iav
mdv
strain
ca
ts
att
phenotyp
partial
character
mechan
attenu
entir
understood
like
involv
multipl
step
replic
cycl
viru
howev
shown
amino
acid
substitut
mdv
aann
use
us
major
contributor
ts
att
phenotyp
case
main
mutat
respons
phenotyp
amino
acid
chang
importantli
genet
signatur
us
mdv
aann
introduc
backbon
human
iav
apuerto
canin
equin
influenza
virus
similar
ts
att
phenotyp
observ
tissu
cultur
cell
well
anim
model
iav
infect
tabl
significantli
current
commerci
avail
ts
ca
eiv
laiv
develop
passag
embryon
chicken
egg
gradual
reduc
temperatur
updat
match
current
circul
eiv
strain
furthermor
observ
optim
match
surfac
antigen
circul
eiv
strain
viru
present
vaccin
lead
suboptim
protect
moreov
mutat
respons
ts
ca
att
phenotyp
eiv
laiv
yet
character
howev
introduc
use
revers
genet
approach
genet
signatur
us
mdv
aann
recent
circul
eiv
strain
abl
gener
new
updat
eiv
laiv
prevent
control
current
circul
eiv
hors
popul
tabl
data
demonstr
contribut
identifi
amino
acid
residu
human
us
mdv
aann
ts
ca
att
phenotyp
also
suggest
common
approach
gener
new
effici
laiv
protect
human
also
anim
devast
effect
iav
infect
multipl
scientif
clinic
evid
demonstr
safeti
profil
licens
season
human
us
laiv
flumist
howev
recent
zhou
et
al
carri
interest
studi
evalu
abil
attenu
us
laiv
revert
ts
att
phenotyp
vitro
intriguingli
author
report
origin
attenu
mdv
might
revert
virul
viru
passag
vitro
gradual
elev
temperatur
moreov
abl
identifi
seven
amino
acid
substitut
respons
revert
phenotyp
tabl
green
figur
role
individu
mutat
analyz
variou
temperatur
evalu
effect
rna
polymeras
activ
viru
replic
author
found
five
amino
acid
chang
found
respect
pa
found
np
andor
found
respect
enough
revert
ts
phenotyp
us
mdv
aann
importantli
vivo
revert
viru
pathogen
mice
compar
mdv
aann
interestingli
amino
acid
chang
respons
revers
phenotyp
map
posit
previous
defin
respons
ts
ca
att
phenotyp
mdv
aann
tabl
figur
red
tsfasman
et
al
studi
revert
viru
mdv
gener
passag
elev
temperatur
embryon
chicken
egg
adapt
viru
lost
ts
ca
phenotyp
sinc
viru
abl
grow
high
titer
also
abil
replic
effici
lower
temperatur
importantli
revert
viru
replic
similar
level
wt
viru
mous
lung
sequenc
revert
viru
discov
nucleotid
chang
result
amino
acid
substitut
pa
np
tabl
magenta
sequenc
confirm
revers
two
ts
mutat
gene
howev
effect
rest
amino
acid
substitut
viral
gene
evalu
import
highlight
describ
revert
mutant
gener
laboratori
condit
howev
vaccin
pathogen
revert
current
mdv
use
human
laiv
observ
demonstr
test
safeti
profil
interestingli
major
amino
acid
substitut
identifi
revert
mutant
locat
polymeras
complex
indic
polymeras
gene
crucial
ts
phenotyp
mainten
mdv
laiv
use
recent
resolv
crystal
structur
bat
iav
polymeras
pdb
id
wsn
np
pdb
id
locat
identifi
amino
acid
variat
revert
origin
ts
virus
analyz
figur
origin
ts
ca
att
amino
acid
chang
local
region
interact
rna
interfac
figur
addit
amino
acid
substitut
origin
mdv
aann
revert
virus
respect
far
apart
linear
sequenc
although
appear
proxim
protein
structur
figur
moreov
basic
k
acid
e
chang
origin
mdv
aann
posit
figur
describ
revert
acid
e
basic
k
chang
structur
region
posit
suggest
region
may
involv
interact
viral
andor
host
cellular
protein
figur
interestingli
except
np
amino
acid
chang
mdv
aann
revert
map
surfac
pa
subunit
np
figur
locat
interfac
pa
figur
posit
could
involv
intermolecular
interact
fact
amino
acid
substitut
identifi
pa
polymeras
subunit
revert
mdv
aann
viru
could
also
involv
interact
subunit
figur
amino
acid
substitut
mdv
aann
appear
part
electrostat
interact
two
domain
might
explain
ts
phenotyp
associ
chang
figur
howev
mani
detail
regard
locat
potenti
function
amino
acid
involv
ts
ca
att
phenotyp
remain
elus
lack
highresolut
structur
depict
interact
polymeras
subunit
interact
viral
np
therefor
difficult
conclud
role
amino
acid
substitut
moreov
possibl
mutat
viral
polymeras
complex
np
respons
ts
ca
att
phenotyp
mdv
aann
affect
known
unknown
interact
viral
andor
host
cellular
protein
addit
mutat
locat
viral
segment
current
licens
human
laiv
genet
studi
multipl
research
use
differ
iav
strain
identifi
amino
acid
chang
viral
polymeras
complex
pa
np
relat
ts
att
phenotyp
analysi
amino
acid
substitut
scope
review
section
limit
provid
exampl
relev
vaccin
design
andor
develop
howev
import
emphas
high
resolut
influenza
polymeras
structur
signific
implic
understand
mechan
involv
ts
att
phenotyp
effici
nuclear
import
assembl
polymeras
subunit
pa
necessari
step
viral
replic
da
costa
et
al
use
circular
dichroism
analysi
studi
pa
linker
structur
wsn
show
structur
disord
domain
moreov
report
pa
linker
mutant
exhibit
ts
phenotyp
reduc
viral
growth
versu
tabl
suggest
consequ
alter
fold
kinet
moreov
use
minigenom
system
ts
phenotyp
pa
mutant
associ
reduc
effici
viral
replicationtranscript
immunofluoresc
assay
also
suggest
ineffici
recruit
nucleu
restrict
temperatur
coexpress
pa
mutant
importantli
ts
virus
attenu
mous
model
infect
still
abl
induc
strong
humor
respons
suggest
strategi
could
use
develop
novel
iav
laiv
candid
interestingli
revert
ts
phenotyp
select
serial
passag
ts
mutant
author
identifi
three
group
revers
tabl
black
chang
amino
acid
pa
protein
revers
residu
initi
mutat
amino
acid
substitut
compon
viral
polymeras
complex
therefor
isol
revert
mutant
ts
virus
allow
identif
compensatori
chang
locat
one
threepolymeras
subunit
could
import
understand
interact
compon
viral
polymeras
complex
data
demonstr
import
studi
iav
polymeras
complex
understand
mechan
behind
ts
ca
phenotyp
order
design
improv
laiv
approach
furthermor
studi
potenti
revert
virus
could
assist
research
elucid
mechan
viral
replic
transcript
well
mechan
attenu
importantli
genet
stabil
ts
laiv
close
evalu
part
att
safeti
profil
new
potenti
iav
laiv
avian
iav
emerg
epidemiolog
concern
instanc
highli
pathogen
avian
iav
hpaiv
continu
circul
mani
asian
countri
threaten
poultri
industri
although
hpaiv
normal
infect
human
strain
caus
sever
infect
human
lethal
rate
henc
prophylact
vaccin
approach
best
option
control
hpaiv
infect
poultri
prevent
transmiss
human
popul
zhang
et
al
gener
recombin
reassort
viru
contain
na
gene
modifi
ha
gene
six
intern
gene
mdv
recombin
viru
subsequ
passag
chicken
embryon
egg
progress
lower
temperatur
author
isol
ts
att
viru
provid
effici
protect
chicken
hpaiv
challeng
importantli
identifi
mutat
pa
polymeras
subunit
tabl
associ
ts
phenotyp
find
demonstr
potenti
use
new
identifi
ts
att
virus
well
respect
mutat
develop
implement
new
laiv
protect
iav
infect
well
prevent
import
economi
loss
potenti
pandem
risk
iav
np
multifunct
protein
involv
vrna
nuclear
import
viral
replic
transcript
particl
encapsid
moreov
role
np
adapt
iav
new
host
report
np
amino
acid
chang
also
involv
ca
andor
ts
phenotyp
pulkina
et
al
studi
iav
mdv
ahong
adapt
growth
low
temperatur
new
viru
contain
amino
acid
chang
intern
protein
two
mutat
map
np
use
revers
genet
technolog
author
gener
recombin
virus
contain
amino
acid
substitut
viral
replic
virus
evalu
differ
temperatur
embryon
egg
reassort
revers
mutat
viral
np
character
nonca
ts
phenotyp
introduct
second
revers
mutat
context
complet
abolish
viru
ca
phenotyp
intrigu
virus
singl
revers
mutat
amino
acid
posit
np
fail
rescu
similarli
noton
et
al
describ
character
avian
influenza
viru
ts
np
mutant
tabl
mutant
viru
gener
chemic
mutagenesi
importantli
introduct
ts
np
amino
acid
chang
backbon
reproduc
ts
phenotyp
despit
drop
viral
titer
restrict
temperatur
np
ts
mutant
viru
show
differ
gene
transcript
genom
replic
andor
viral
protein
synthesi
compar
wt
viru
howev
ts
mutant
np
viru
releas
sixfold
viru
particl
wt
interestingli
viral
particleplaqu
form
unit
pfu
ratio
ts
mutant
np
higher
wt
numer
virion
exhibit
nonstandard
morpholog
author
reveal
np
ts
mutat
affect
interact
probabl
assembl
viral
particl
importantli
studi
demonstr
ts
iav
affect
one
viral
life
cycl
step
viral
rna
synthesi
viru
morphogenesi
releas
moreov
studi
confirm
ts
amino
acid
substitut
specif
iav
strain
could
display
similar
ts
phenotyp
introduc
differ
iav
backbon
recent
jang
et
al
use
previous
develop
ts
ca
iav
analyz
genet
signatur
viru
character
contribut
identifi
amino
acid
chang
ts
ca
phenotyp
iav
mutant
viru
select
multipl
serial
passag
embryon
egg
progress
lower
suboptim
temperatur
coldpassag
mutant
exhibit
ts
ca
phenotyp
moreov
mice
show
clinic
sign
even
high
titer
infect
gener
ts
ca
mutant
viru
reassort
viru
carri
ha
na
segment
ahong
genet
background
ca
process
nucleotid
chang
introduc
six
intern
viral
gene
among
nucleotid
substitut
result
amino
acid
substitut
seven
viral
protein
four
three
two
pa
two
np
three
two
one
nonstructur
protein
tabl
phenotyp
analysi
singl
multiplegen
reassort
virus
suggest
viral
np
major
contributor
ts
ca
phenotyp
ts
ca
iav
howev
viral
gene
also
includ
mutat
respons
viral
attenu
mice
contribut
six
intern
gene
least
ca
phenotyp
np
pa
ns
ts
phenotyp
np
pa
ns
addit
multipl
gene
reassort
virus
contain
combin
polymeras
compon
pa
provid
margin
effect
ca
ts
phenotyp
compar
ts
ca
phenotyp
singl
np
gene
moreov
combin
three
polymeras
subunit
pa
np
gene
author
observ
increas
phenotyp
ca
ts
suggest
addit
effect
sever
amino
acid
residu
polymeras
complex
howev
studi
author
identifi
specif
amino
acid
residu
viral
protein
involv
ca
ts
att
phenotyp
although
iav
viral
machineri
rna
synthesi
repres
import
target
introduc
mutat
gener
laiv
ts
ca
att
phenotyp
feasibl
amino
acid
chang
viral
protein
could
also
similarli
consid
explor
develop
new
ts
ca
att
laiv
structur
protein
iav
virion
multipl
function
viral
infect
dissoci
vrnp
requir
entri
vrnp
cytoplasm
host
cell
initi
infect
moreov
associ
iav
vrna
np
step
indispens
format
vrnp
nuclear
export
liu
et
al
introduc
sever
amino
acid
substitut
backbon
understand
role
zinc
finger
motif
rklkr
domain
involv
rna
bind
viral
assembl
replic
observ
modifi
zinc
finger
motif
iav
reduc
viral
growth
slightli
hand
introduc
amino
acid
substitut
rklkr
domain
iav
reduct
nuclear
export
vrnp
viral
replic
observ
interestingli
doubl
iav
mutant
display
ts
phenotyp
tabl
moreov
viru
contain
substitut
reduc
ratio
np
viral
particl
weaker
bind
rnp
importantli
substitut
requir
prevent
nuclear
local
restrict
temperatur
singl
amino
acid
substitut
either
posit
minim
effect
nuclear
local
viral
likewis
nogal
et
al
shown
split
segment
ms
produc
singl
transcript
rather
altern
splice
result
viru
ts
att
phenotyp
abl
protect
lethal
challeng
wt
notabl
protect
efficaci
modifi
ms
viru
better
obtain
ts
ca
demonstr
feasibl
use
split
approach
segment
alon
combin
viral
ns
develop
safe
immunogen
protect
laiv
defens
mechan
provid
host
innat
immun
system
restrict
iav
infect
therefor
effici
replic
interferon
ifn
compet
system
iav
regul
product
ifn
activ
ifninduc
protein
inhibit
viru
replic
iav
ns
genom
segment
encod
multifunct
protein
mainli
involv
counteract
host
innat
immun
respons
modul
viru
pathogenesi
interestingli
describ
mutat
protein
confer
ts
phenotyp
iav
differ
mechan
fact
iav
mutant
express
delet
andor
truncat
show
defici
replic
nonpermiss
temperatur
garaigorta
et
al
identifi
ts
mutant
name
contain
three
amino
acid
chang
protein
respons
ts
phenotyp
replic
gene
express
viru
slightli
alter
howev
mutat
high
impact
viru
particl
format
suggest
could
involv
morphogenesi
iav
interestingli
mutat
introduc
backbon
viru
attenu
compar
wt
consist
previou
result
moreov
recombin
viru
contain
mutat
respons
ts
ca
att
phenotyp
mdv
aann
alon
laiv
combin
mutat
sever
impair
replic
make
plaqu
restrict
temperatur
compar
laiv
could
like
attribut
mutat
affect
viru
egressbud
addit
show
higher
attenu
vivo
laiv
abl
stimul
similar
humor
respons
abl
protect
lethal
challeng
wt
viru
laiv
result
highlight
possibl
increas
safeti
profil
current
mdv
aann
laiv
without
affect
immunogen
protect
efficaci
introduc
mutat
recent
variabl
protein
circul
iav
isol
infect
subject
analyz
multipl
amino
acid
chang
identifi
consequ
mutat
inhibit
ifn
respons
pathogenesi
viru
evalu
show
mutat
impair
abil
protein
inhibit
host
gene
express
interestingli
one
identifi
mutat
associ
ts
phenotyp
moreov
show
viru
encod
mutat
attenu
vivo
compar
viru
contain
wt
protein
studi
relev
gener
novel
laiv
also
order
identifi
new
residu
essenti
function
includ
identif
mutat
use
risk
assess
circul
pathogen
virus
human
popul
last
decad
season
iav
vaccin
shown
low
effect
protect
human
annual
viral
infect
multipl
reason
affect
effici
laiv
iiv
rout
administr
laiv
administ
intranas
rout
mimick
natur
infect
establish
mucos
immun
respiratori
tract
hand
iiv
administ
intramuscularli
lead
suboptim
induct
immun
respons
mucosa
ii
intrins
immunogen
vaccin
compon
mainli
ha
protein
respons
differ
observ
efficaci
season
iiv
andor
laiv
iii
emerg
viral
strain
variant
distinct
select
vaccin
strain
given
influenza
season
result
signific
loss
vaccin
effect
iv
establish
influenzaspecif
b
tcell
memori
sinc
mdv
iav
laiv
remain
constant
season
viral
ha
na
gene
updat
suggest
preexist
immun
intern
protein
mdv
could
limit
respons
laiv
must
replic
order
immunogen
provid
protect
subsequ
viral
infect
fact
could
one
reason
low
efficaci
laiv
understand
season
iav
vaccin
influenc
preexist
immun
import
develop
nextgener
iav
vaccin
moreov
futur
strategi
develop
new
vaccin
iav
highli
desir
might
requir
modifi
mdv
aann
current
use
prepar
season
pandem
laiv
recent
publish
highresolut
structur
iav
polymeras
complex
new
advanc
studi
mechan
vrna
synthesi
expand
current
knowledg
threaten
human
respiratori
pathogen
provid
research
opportun
analyz
mechan
virul
transmiss
andor
host
adapt
addit
understand
mechan
regul
viral
polymeras
complex
could
assist
ration
design
safer
immunogen
protect
laiv
review
discuss
use
ts
ca
att
mutat
iav
gener
laiv
approach
could
provid
deliber
method
viral
attenu
could
applic
treatment
either
season
andor
pandem
iav
infect
viral
strain
infect
host
speci
furthermor
combin
polymeras
thermosensit
approach
assur
higher
attenu
profil
develop
safer
laiv
well
advanc
gener
univers
iav
vaccin
univers
vaccin
candid
requir
induc
crossprotect
broadli
neutral
immun
stimul
humor
cellular
adapt
immun
respons
moreov
univers
vaccin
avoid
necess
annual
revaccin
given
laiv
typic
induc
stronger
antibodi
tcell
mediat
respons
mucosa
protect
repres
excel
option
univers
vaccin
platform
final
insight
molecular
mechan
viral
replic
transcript
could
provid
import
inform
ration
structurebas
design
ts
ca
att
laiv
well
identif
novel
antivir
prevent
treatment
respect
iav
infect
